EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 275 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,000 | -40.0% | 95 | -17.4% | 0.00% | 0.0% |
| Q1 2022 | $5,000 | -85.3% | 115 | -85.1% | 0.00% | -83.3% |
| Q4 2021 | $34,000 | -64.2% | 773 | -59.3% | 0.01% | -64.7% |
| Q3 2021 | $95,000 | -20.2% | 1,900 | +0.8% | 0.02% | -22.7% |
| Q2 2021 | $119,000 | +11.2% | 1,885 | +63.8% | 0.02% | -12.0% |
| Q1 2021 | $107,000 | -1.8% | 1,151 | -5.4% | 0.02% | -7.4% |
| Q4 2020 | $109,000 | +541.2% | 1,217 | +628.7% | 0.03% | +350.0% |
| Q3 2020 | $17,000 | +30.8% | 167 | 0.0% | 0.01% | +20.0% |
| Q2 2020 | $13,000 | +44.4% | 167 | +1.8% | 0.01% | +25.0% |
| Q1 2020 | $9,000 | – | 164 | +3180.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 5 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | – | 5 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |